Lower than three weeks after asserting an bold $110 million growth into Virginia, the place adult-use marijuana gross sales are anticipated to start someday subsequent yr, Curaleaf Holdings’ buy of competitor The Cannabist Firm Holdings’ belongings within the state is off.
The rationale why New York-based Curaleaf gained’t buy a vertically built-in medical hashish allow in any case? A competing supply for a complete of $160 million materialized, Curaleaf stated in a press launch Friday.
The Curaleaf deal, finalized Dec. 1, was set to shut within the first quarter of 2026 and included Cannabist’s 5 present shops within the Richmond, Virginia, space and an 83,000-square-foot cultivation operation, with the best to open a sixth retailer.
However on Thursday, the identical day President Donald Trump issued an govt order downgrading hashish’ standing beneath federal legislation, Massachusetts-based Cannabist stated it is going to promote its Virginia allow to an affiliate of Millstreet Credit score Fund for $130 million, “topic to adjustment.”
Millstreet is a Boston-based hedge fund, in keeping with Securities and Change Fee filings.
Curaleaf’s supply was for $80 million in money up entrance, $20 million to be paid inside 30 days and a $10 million promissory word at 6% curiosity.
It wasn’t instantly clear whether or not the extra beneficiant deal was immediately associated to the prospects of hashish changing into a Schedule 3 drug.
Will increase value for marijuana MSO after Trump rescheduling
In accordance with a Cannabist press launch, the deal is for $117.5 million in money “payable … upon closing.” In accordance with Curaleaf, that deal additionally contains “the idea of a $30 million lease legal responsibility.”
Proceeds from the sale will fulfill debt coming due on the finish of 2028, in keeping with The Cannabist Co.
Curaleaf continues to be due a $3.3 million “break-up charge” from Cannabist on account of the latter firm accepting the extra profitable supply, in keeping with a press launch.
Virginia adult-use marijuana gross sales potential
Virginia’s medical hashish market is severely restricted by legislation to solely 5 vertically built-in permits, every of which is restricted to a selected geographic area.
Regardless of that, the state reported almost $30 million in gross sales in July and August, the primary two months of state-mandated track-and-trace monitoring.
Grownup-use hashish gross sales might attain $780 million within the first full yr of gross sales and exceed $1.09 billion by the second yr, in keeping with the MjBiz Factbook.
In accordance with a 2020 research commissioned by state lawmakers, Virginia might assist between:
- 100 and 800 cultivation permits
- 30 and 150 processing or distribution licenses
- 200 and 600 retail licenses
The opposite 4 present medical marijuana permits are held by:
- Miami-based MSO Ayr Wellness, which has but to open a dispensary and just lately offered off belongings, together with the Virginia allow, to collectors
- Boca Raton, Florida-based Jushi
- Chicago-based Inexperienced Thumb Industries
- Chicago-based Verano Holdings Corp.
Subscribe to the MJBiz Factbook
Unique trade knowledge and evaluation that will help you make knowledgeable enterprise choices and keep away from expensive missteps. All of the details, not one of the hype.
What you’re going to get:
- Month-to-month and quarterly updates, with new knowledge & insights
- Monetary forecasts + capital funding tendencies
- State-by-state information to rules, taxes & market alternatives
- Annual survey of hashish companies
- Client insights
- And extra!
In an adult-use state of affairs – thought of to be an inevitability, with Democratic Gov.-elect Virginia Spanberger pledging to lastly launch adult-use gross sales within the South – it stays to be seen whether or not present medical operators will get first dibs as in Maryland, or whether or not regulators will give choice to small enterprise, a la New York state.
